MEDICINOVA, INC. Retained Earnings
MEDICINOVA, INC. (MNOV) had Retained Earnings of -$443.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$443.65M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$441.34M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$438.75M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$435.95M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$443.65M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$441.34M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$438.75M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$435.95M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$432.90M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$429.62M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$426.75M 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$423.94M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$421.08M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$418.46M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$415.70M 10-K · filed 2025-02-19 | |
| 2023-09-30 | -$413.64M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$412.92M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$410.05M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$407.13M 10-K · filed 2024-02-15 | |
| 2022-09-30 | -$404.13M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$400.48M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$396.45M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$393.06M 10-K/A · filed 2023-03-28 | |
| 2021-09-30 | -$390.98M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$387.40M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$383.11M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$382.93M 10-K · filed 2022-02-16 | |
| 2020-09-30 | -$379.94M 10-Q · filed 2020-10-26 | |
| 2020-06-30 | -$376.24M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | -$371.79M 10-Q · filed 2020-04-23 | |
| 2019-12-31 | -$369.07M 10-K · filed 2021-02-19 | |
| 2019-09-30 | -$367.09M 10-Q · filed 2019-10-24 | |
| 2019-06-30 | -$364.71M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | -$360.83M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | -$356.13M 10-K · filed 2020-02-13 | |
| 2018-09-30 | -$355.92M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | -$349.14M 10-Q · filed 2018-07-23 | |
| 2018-03-31 | -$346.00M 10-Q · filed 2018-04-25 | |
| 2017-12-31 | -$341.46M 10-K · filed 2019-02-13 | |
| 2017-09-30 | -$339.85M 10-Q · filed 2017-10-23 | |
| 2017-06-30 | -$336.10M 10-Q · filed 2017-07-26 | |
| 2017-03-31 | -$333.31M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | -$330.29M 10-K · filed 2018-02-13 | |
| 2016-09-30 | -$328.84M 10-Q · filed 2016-10-25 | |
| 2016-06-30 | -$326.01M 10-Q · filed 2016-07-26 | |
| 2016-03-31 | -$322.81M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | -$319.43M 10-K · filed 2017-02-14 | |
| 2015-09-30 | -$316.69M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | -$315.08M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | -$312.80M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$310.58M 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$308.20M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$305.86M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | -$303.74M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$301.39M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$303.68M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$301.44M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$298.65M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | -$297.32M 10-K · filed 2014-03-27 | -$296.23M 10-K · filed 2013-03-28 |
| 2012-09-30 | -$293.80M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$291.42M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$289.14M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$285.27M 10-K · filed 2013-03-28 | |
| 2011-09-30 | -$281.77M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$277.88M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$267.54M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |